| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4218887 | Academic Radiology | 2010 | 7 Pages |
Abstract
The prepared MBs conjugated with cRGD demonstrated a sufficient residence time to attach to the target integrin of tumor tissues. This finding suggests that the MBs are a potential molecular contrast agent that enables characterization of tumor angiogenesis and the monitoring of antitumor and antiangiogenic therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Hong Young Jun, Seong Hoon MD, Hun Soo MD, Kwon-Ha MD, PhD,